Intracranial Stents Market to hit US$ 702.8 million by 2031 | Penumbra, Inc., Medtronic plc, Stryker Corporation, Boston Scientific Corporation Inc.

"The Intracranial Stents Market was valued US$ 360 million in 2021 and is estimated to reach US$ 702.8 million by 2031, growing at a CAGR of 8.98% during the forecast period (2024-2031)." As per DataM intelligence research report

Market growth opportunities(2025-2031):

The intracranial stents market is gaining significant momentum, driven by the expanding need for minimally invasive treatments for cerebrovascular conditions like brain aneurysms and intracranial stenosis. Technological advances such as self-expanding, balloon-expandable, and flow-diveret stents are enhancing procedural precision and broadening clinical applicability. Improved early-stage diagnosis capabilities are facilitating prompt intervention, while rising disease awareness is boosting demand. Strategic partnerships between device developers and healthcare institutions are accelerating adoption and deployment globally.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/intracranial-stents-market?sp

Intracranial Stents Market: Recent Industry Developments

✅ In July 2025, Stryker Neurovascular unveiled the Neuroform AtlasTM 2.0 Stent System featuring improved trackability and vessel conformability.It is designed to treat complex intracranial aneurysms with greater precision.Commercial rollout has begun across the U.S., EU, and Asia-Pacific.

✅ In June 2025, Medtronic gained FDA approval for the PipelineTM Vantage Flow Diverter with Shield TechnologyTM.The device reduces clot formation risk while promoting vessel healing in large aneurysms.Nationwide U.S. launch will include dedicated physician training workshops.

✅ In May 2025, MicroVention (Terumo) launched the LVIS® EVO Stent in Europe following CE Mark clearance.Engineered for stent-assisted coiling, it offers exceptional fluoroscopic visibility.Clinicians report smoother navigation in tortuous vessel anatomies.

✅ In April 2025, Balt secured $55 million to fast-track development of next-gen self-expanding intracranial stents.The focus is on ultra-low-profile systems for distal vessel access.First-in-human trials are targeted for early 2026.

✅ In March 2025, Phenox GmbH partnered with Brainomix to integrate AI imaging with stent-based stroke interventions.The collaboration aims to optimize patient selection and procedural outcomes.Pilot deployments have started in leading European stroke centers.

Intracranial Stents Market: Drivers

Rising cases of stroke, brain aneurysms, intracranial stenosis, and hypertension are fuelling demand for intracranial stents. Growing geriatric populations further increase vulnerability to cerebrovascular conditions. The shift toward minimally invasive neurovascular interventions is prompting hospitals and clinics to adopt stenting techniques more widely. Technological innovations are reinforcing clinical confidence and physician preference in favor of these devices. Improved healthcare infrastructure and increased access in emerging regions are opening new markets for advanced treatment options.

Intracranial Stents Market: Technological Advancements

✦ Flow-diverters are emerging as preferred solutions for single-device aneurysm management, improving occlusion rates and reducing retreatment needs.
✦ Bioresorbable polymers are being introduced to address the challenges of permanent metal implants, offering temporary support during healing and reducing long-term complications.
✦ Drug-eluting stent technologies are being explored for intracranial stenosis, aiming to lower restenosis risks and support vessel patency post-implantation.
✦ Hydrophilic coatings and structural refinements are enhancing safety profiles, reducing thromboembolic events, and optimizing delivery through tortuous vascular pathways.
✦ Low-profile, highly navigable designs are enabling improved access in complex cerebrovascular anatomies, particularly important for delicate neurointerventional procedures.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/intracranial-stents-market?sp

Segment Covered in the Intracranial Stents Market:

➥ By Product Type: Self-expanding Stents, Balloon Expanding Stents, Stent-assisted Coil Embolization
➥ By Disease Indication: Intracranial Stenosis, Brain Aneurysm
➥ By Design: Open-cell, Closed-cell
➥ By Uses: Neuroform, Solitaire, Enterprise, Leo Plus, Wingspan
➥ By End-User: Hospitals, Ambulatory Surgical Centers, Clinics, Others

Strategic Players Driving the Intracranial Stents Market Forward:

Penumbra, Inc., Medtronic plc, Stryker Corporation, Boston Scientific Corporation Inc., Terumo Corporation, Cook Medical, DePuy Synthes, Balt Extrusion S.A., MicroPort Scientific Corporation, and Abbott Laboratories among others.

Why Purchase the Report for Intracranial Stents Market?:

➠ Technology & Innovation: Tracks clinical trials and upcoming pharmaceutical advancements to stay ahead in product development.
➠ Market Positioning & Competitive Strategy: Analyzes product performance, market share, and competitor tactics for strategic decision-making.
➠ Real-World Evidence & Physician Insights: Incorporates patient data and physician behavior to align products with actual healthcare needs.
➠ Pricing & Market Access: Reviews reimbursement trends and access models to optimize product pricing and launch strategies.
➠ Regulatory & Industry Shifts: Covers policy changes, health system dynamics, and technology trends impacting market opportunities.
➠ Regional Growth & Expansion: Identifies high-growth markets and investment opportunities for geographic expansion.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=intracranial-stents-market

Regional Analysis for Intracranial Stents Market:

North America leads the market, supported by sophisticated healthcare infrastructure, strong R&D networks, and favorable reimbursement frameworks.
Europe maintains robust growth, driven by high disease prevalence, established neurovascular treatment protocols, and innovation-friendly healthcare systems.
Asia-Pacific is the fastest growing region, spurred by expanding healthcare infrastructure, rising patient demand, and increasing investment in advanced neurological care across countries like China, India, and Japan.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.